CA2397253A1 - Combinaisons d'inhibiteurs de farnesyl proteine transferase et de derives antitumoraux d'anthracycline - Google Patents

Combinaisons d'inhibiteurs de farnesyl proteine transferase et de derives antitumoraux d'anthracycline Download PDF

Info

Publication number
CA2397253A1
CA2397253A1 CA002397253A CA2397253A CA2397253A1 CA 2397253 A1 CA2397253 A1 CA 2397253A1 CA 002397253 A CA002397253 A CA 002397253A CA 2397253 A CA2397253 A CA 2397253A CA 2397253 A1 CA2397253 A1 CA 2397253A1
Authority
CA
Canada
Prior art keywords
6alkyl
hydrogen
6alkyloxy
formula
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002397253A
Other languages
English (en)
Inventor
Mary Ellen Margaret Rybak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2397253A1 publication Critical patent/CA2397253A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des combinaisons d'un inhibiteur de farnésyl-transférase et d'un dérivé d'anthracycline destinées à inhiber la croissance de cellules tumorales et utiles dans le traitement du cancer.
CA002397253A 2000-02-29 2001-02-26 Combinaisons d'inhibiteurs de farnesyl proteine transferase et de derives antitumoraux d'anthracycline Abandoned CA2397253A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00200696 2000-02-29
EP00200696.3 2000-02-29
PCT/EP2001/002166 WO2001064197A2 (fr) 2000-02-29 2001-02-26 Combinaisons d'inhibiteurs de farnesyl proteine transferase et de derives antitumoraux d'anthracycline

Publications (1)

Publication Number Publication Date
CA2397253A1 true CA2397253A1 (fr) 2001-09-07

Family

ID=8171115

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002397253A Abandoned CA2397253A1 (fr) 2000-02-29 2001-02-26 Combinaisons d'inhibiteurs de farnesyl proteine transferase et de derives antitumoraux d'anthracycline

Country Status (5)

Country Link
EP (1) EP1267872A2 (fr)
JP (1) JP2003525237A (fr)
AU (1) AU2001244167A1 (fr)
CA (1) CA2397253A1 (fr)
WO (1) WO2001064197A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060166907A1 (en) * 2002-09-27 2006-07-27 Gregoire Prevost Composition for the treatment of nasopharyngeal carcinoma and method of use thereof
KR20070001922A (ko) 2003-12-12 2007-01-04 와이어쓰 심장혈관질환 치료에 유용한 퀴놀린
EP2545919A1 (fr) 2005-12-23 2013-01-16 Link Medicine Corporation Traitement de formes de synucleinopathie
WO2014062658A1 (fr) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv Modulateurs de ror-gamma-t de type quinolinyle à liaison méthylène
EP2909189B8 (fr) 2012-10-16 2017-04-19 Janssen Pharmaceutica NV Modulateurs de ror-gamma-t de type quinolinyle à liaison hétéroaryle
CN105073729A (zh) 2012-10-16 2015-11-18 詹森药业有限公司 RORγt的苯基连接的喹啉基调节剂
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9346782B2 (en) 2013-10-15 2016-05-24 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
WO2015057626A1 (fr) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Modulateurs quinolinyl de roryt

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW349948B (en) * 1995-10-31 1999-01-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 2-quinolone derivatives
TR199800825T2 (xx) * 1995-12-08 1998-08-21 Janssen Pharmaceutica N.V. Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri.
TW591030B (en) * 1997-03-10 2004-06-11 Janssen Pharmaceutica Nv Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with N- or C-linked imidazoles
RU2205831C2 (ru) * 1997-04-25 2003-06-10 Янссен Фармацевтика Н.В. Хиназолиноны, ингибирующие фарнезилтрансферазу
JP4502503B2 (ja) * 1997-12-22 2010-07-14 シェーリング コーポレイション 増殖性の疾患を処置するためのベンゾシクロヘプタピリジン化合物および抗腫瘍剤の組合せ
EP1087770A4 (fr) * 1998-06-15 2001-11-14 Merck & Co Inc Inhibiteurs de prenyl-proteine transferase
EP1091736A4 (fr) * 1998-07-02 2001-10-24 Merck & Co Inc Inhibiteurs de prenyl-proteine transferase
PT1140935E (pt) * 1998-12-23 2003-10-31 Janssen Pharmaceutica Nv Derivados da quinolina 1,2-ciclizada

Also Published As

Publication number Publication date
JP2003525237A (ja) 2003-08-26
WO2001064197A2 (fr) 2001-09-07
EP1267872A2 (fr) 2003-01-02
WO2001064197A3 (fr) 2002-03-21
AU2001244167A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
CA2397349A1 (fr) Inhibiteur de farnesyl proteine transferase associe a un anticorps her2
CA2397657A1 (fr) Combinaisons d'inhibiteur de farnesyl proteine transferase et de composes de platine
CA2397240A1 (fr) Inhibiteur de farnesyl proteine transferase associe a des composes de camptothecine
CA2396865C (fr) Inhibiteurs de la farnesyl proteine transferase pour le traitement du cancer du sein
CA2397256A1 (fr) Combinaisons de farnesyl-proteine transferase avec des derives de podophyllotoxine anti-tumoraux
CA2397446A1 (fr) Combinaisons d'inhibiteur de farnesyl proteine transferase et d'agents d'alkylation antitumoraux
CA2397558A1 (fr) Regime posologique
CA2397690A1 (fr) Inhibiteur de farnesyl proteine transferase associe a des derives nucleosidiques anti-cancereux
CA2397694A1 (fr) Combinaisons d'inhibiteur de farnesyl-proteine transferase
CA2397448A1 (fr) Inhibiteur de farnesyl proteine transferase associe a d'autres agents anti-cancereux
CA2397425A1 (fr) Combinaisons d'inhibiteur de farnesyl-proteine transferase avec compose a base de taxane
CA2397253A1 (fr) Combinaisons d'inhibiteurs de farnesyl proteine transferase et de derives antitumoraux d'anthracycline
US20030050323A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor podophyllotoxin derivatives
US20030060480A1 (en) Farnesyl protein transferase inhibitor combinations with vinca alkaloids
CA2397475A1 (fr) Combinaisons d'inhibiteurs de farnesyl proteine transferase et de vinca-alcaloides
US20030125268A1 (en) Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives

Legal Events

Date Code Title Description
FZDE Dead